• 2023.0306

    The Development of Reporting Guideline of clinical Practice Guidelines in General Practice provides detailed guidance for the makers and writers of the general practice guidelines, which will further improve the reporting quality of the general practice guidelines, especially the Chinese general practice guidelines, and promote the application in general medical practice, thus finally improving the quality of primary medical care.

  • 2023.0220

    Professor Gordon Guyatt of McMaster University and Professor Victor Montori of the Mayo Clinic jointly published a paper in the British Medical Journal (BMJ) entitled: Guidelines should consider clinicians' time needed to treat on January 3, 2023.

  • 2022.1126

    IGEST is a generic tool for screening guidelines for any specialty, target population, and healthcare organization, but it is intended only as a screening tool, primarily for quickly assessing guideline quality and determining whether they can be adopted or adapted in other settings, and is not a substitute for some of the more complex guideline quality evaluation tools.

  • 2022.1031

    In July 2022, Jose F. Meneses-Echavez et al. from the Norwegian Institute of Public Health published an article in the Journal of Clinical Epidemiology entitled "Evidence to decision frameworks enabled structured and explicit development of healthcare recommendations". The aim of this study was to identify and describe the processes suggested for the formulation of healthcare recommendations in healthcare guidelines available in guidance documents.

Register MORE
  • 2023.0523
    Functional movement disorders (FMDs), also known as psychogenic movement disorders (PMDs), are very representative functional neurological diseases, and the etiology and pathogenesis of FMDs are not yet clear. FMDs are characterized by various movement dysphylaxis symptoms, or symptoms inconsistent with known organic diseases. Most patients with FMDs have a history of mental illness such as stress, anxiety or depression, and some patients are even affected by stress for a long time. At present, FMDs account for 3-6% of movement disorder clinics, and there is no accurate epidemiological data in China. The age of FMDs onset is 35 to 50 years, and it is more common in women, but the actual incidence is wider. FMDs have now become an important subtype of movement disorders, but most clinicians (especially medical, neurologists, and psychiatrists) are poorly aware of the disease and are often helpless when dealing with such patients. The original version of Chinese expert consensus on the diagnosis and treatment of functional movement disorders was firstly developed in 2021 in China based on research and clinical experience from experts. Now, we are aiming the second version consensus with revisement and update based on original version.
Registration process and operational mode of a CPG registry